The “Born in Guangzhou Cohort Study” is looking to recruit 50,000 baby-mother sets by 2020. Since 2012, 1.6 million samples have been collected for the project and the some of the first findings have been published.
Studies of breast cancer do not take sufficient account of patients’ race, ethnicity, economic status, education level, health insurance coverage, and other social factors, a group of scientists argue.
Cancer Research UK Cambridge Institute is pushing for the use of genetic testing to transform treatment of breast cancer with the Personalised Breast Cancer Programme.
The California State Legislature has approved a budget including $2 million for a pilot project to fund clinical whole genome sequencing as a first line diagnostic test.
To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
The Swiss drugmaker has clearly noticed the genomic profiling group’s ability to personalise cancer care, now that it will take complete ownership of the company.
Elizabeth Holmes, Founder of disgraced biotech Theranos, and her former COO, Ramesh ‘Sunny’ Balwani, have been indicted with alleged wire fraud schemes in the state of California.
Using genome-wide genetic approaches, researchers systematically screened for the loss of an additional gene that could rescue a genetic disease, and found it.
Sometimes a new company catches the eye, and this week that company is nference, a Cambridge MA-based start-up developing AI technology to discover and develop drugs more effectively. AI is no longer new in this space, so why does nference grab our attention?